BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.
Breast Cancer Res Treat
; 166(3): 775-785, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-28822007
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
BRCA1 Protein
/
Triple Negative Breast Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2017
Type:
Article
Affiliation country:
Netherlands